Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity.

Plasmodium vivax is the most widespread and difficult to treat cause of human malaria. The development of vaccines against the blood stages of P. vivax remains a key objective for the control and elimination of vivax malaria. Erythrocyte binding-like (EBL) protein family members such as Duffy bindin...

Full description

Bibliographic Details
Main Authors: Jin-Hee Han, Jee-Sun Cho, Jessica J Y Ong, Ji-Hoon Park, Myat Htut Nyunt, Edwin Sutanto, Hidayat Trimarsanto, Beyene Petros, Abraham Aseffa, Sisay Getachew, Kanlaya Sriprawat, Nicholas M Anstey, Matthew J Grigg, Bridget E Barber, Timothy William, Gao Qi, Yaobao Liu, Richard D Pearson, Sarah Auburn, Ric N Price, Francois Nosten, Laurent Rénia, Bruce Russell, Eun-Taek Han
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-07-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0008202